Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL2396755 | 1.00 | CA2 (0.40) | CA2LMNA | |
| Phosphoric Acid SCHEMBL29173940 | 0.96 | CA2 (0.38) | CA2 | |
| Phosphoric Acid SCHEMBL28014825 | 0.96 | CA2 (0.38) | CA2 | |
| Phosphoric Acid SCHEMBL17555384 | 0.96 | CA2 (0.43) | CA2LMNA | |
| Phosphoric Acid SCHEMBL6383668 | 0.96 | CA2 (0.43) | CA2LMNA | |
| Phosphoric Acid SCHEMBL8505699 | 0.96 | CA2 (0.43) | CA2LMNA | |
| Phosphoric Acid SCHEMBL854955 | 0.96 | — | — | |
| Phosphoric Acid SCHEMBL7601322 | 0.96 | CA2 (0.43) | CA2LMNA | |
| Phosphoric Acid SCHEMBL675651 | 0.96 | — | — | |
| Phosphoric Acid SCHEMBL6036466 | 0.96 | CA2 (0.43) | CA2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118191132-A | Analysis method for detecting impurities including nitrosamine in levosalbutamol hydrochloride | 山东泰合医药科技有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-104592049-A | Raw material medicine and preparations of pregabalin | LI XINGHUI | 2015-05-06 | — | — | CN | claimed |
| CN-103159636-B | Aminomethyl caproic acid derivatives and uses | LI XINGHUI | 2015-02-25 | — | — | CN | claimed |
| CN-103159636-A | Aminomethyl caproic acid derivatives and uses | LI XINGHUI | 2013-06-19 | — | — | CN | claimed |
| CN-102507836-A | Quality detection method of menstruation regulating pill | DARENTANG PHARMACEUTICAL FACTORY TIANJIN ZHONGXIN PHARMACEUTICAL GROUP CO LTD | 2012-06-20 | — | — | CN | claimed |
| CN-101303333-A | Method for evaluating beer aging degree with high-efficiency liquid phantom method | UNIV JIANGNAN (CN) | 2008-11-12 | — | — | CN | claimed |
| CN-118191132-A | Analysis method for detecting impurities including nitrosamine in levosalbutamol hydrochloride | 山东泰合医药科技有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-115537036-B | Process for purifying safflower red pigment by macroporous resin | 浙江中医药大学 | 2024-05-10 | — | — | CN | disclosed |
| CN-115703711-A | Preparation method of levalbuterol alkoxide | 南京济群医药科技股份有限公司 | 2023-02-17 | — | — | CN | disclosed |
| CN-111175423-B | Method for analyzing nedaplatin | 江苏奥赛康药业有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-112305088-B | Analysis method of 4-demethoxydaunorubicin related substances for injection | 南京正大天晴制药有限公司 | 2022-07-05 | — | — | CN | disclosed |
| CN-112409382-A | Synthesis method of cefetamet pivoxil hydrochloride | 浙江普洛得邦制药有限公司 | 2021-02-26 | — | — | CN | disclosed |
| CN-112409362-A | Crystal of intermediate compound of lapatinib and preparation method thereof | 苏州鹏旭医药科技有限公司 | 2021-02-26 | — | — | CN | disclosed |
| CN-1600817-A | Yellow pigment of safflower preparation method and application | YONGNING PHARMACEUTIC MFG PLAN (CN) | 2005-03-30 | — | — | CN | disclosed |
| US-20050064028-A1 | Pharmaceutical compositions containing plasma protein | SICOR INC. | 2005-03-24 | — | — | US | disclosed |
| US-6743826-B1 | DELIVERY OF COMPOUNDS HAVING POOR WATER SOLUBILITY; BINDING AFFINITY TO PLASMA PROTEINS BY WAY OF NON-COVALENT BONDS; SERUM ALBUMIN AND GAMMA GLOBULIN; PACLITAXEL, AMPHOTERICIN B, CAMPTOTHECIN, CARBAMAZEPINE, CYCLOSPORIN A; PROPOFOL | HUMAN RT (HU) | 2004-06-01 | — | — | US | disclosed |
| US-6737085-B2 | NATURALLY DERIVED ANTIDEPRESSANT COMPOSITION IN THE FORM OF A FOOD, DIETARY SUPPLEMENT, MEDICINE OR THE LIKE THAT CONTAINS NEITHER HYPERICIN NOR HYPERFORIN AND IS SAFER EVEN DURING EXTENDED ADMINISTRATION, FOR THERAPY OF DEPRESSION | TOKIWA PHYTOCHEMICAL CO., LTD. (JP) | 2004-05-18 | — | — | US | disclosed |
| EP-0981375-B1 | PHARMACEUTICAL COMPOSITIONS CONTAINING PLASMA PROTEIN | HUMAN RT (HU) | 2003-01-08 | — | — | EP | disclosed |
| US-20020090403-A1 | Antidepressant | TOKIWA PHYTOCHEMICAL CO., LTD. (JP) | 2002-07-11 | — | — | US | disclosed |
| US-6113907-A | MEASUREMENT OF SAMPLE, BINDING AND DETERMINATION OF HYPERICIN CONCENTRATION FOR MUSCARINIC M1 RECEPTORS | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2000-09-05 | — | — | US | disclosed |